Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCG vaccine + hepatitis B vaccine
- Development stage
- Unknown
- Lead developer
- Murdoch Children's Research Institute
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal, Intramuscular
01
Overview
This refers to the co-administration of the Bacille Calmette-Guérin (BCG) vaccine and the Hepatitis B vaccine as investigated in the Early Life Vaccines and Immunity Study (ELVIS) conducted by the Murdoch Childrens Research Institute. The study is a randomized controlled trial designed to evaluate the heterologous (non-specific) immunomodulatory effects of these two standard neonatal vaccines when administered at birth. BCG is a live attenuated bacterial vaccine derived from *Mycobacterium bovis* used for tuberculosis prevention, while the Hepatitis B vaccine is a recombinant protein-based vaccine. The research specifically examines how the timing and combination of these vaccines influence neonatal cytokine responses and innate immune development, with findings suggesting that Hepatitis B vaccine co-administration can modulate the heterologous effects of BCG in a sex-differential manner.
- Other names
- Early Life Vaccines and Immunity StudyBCG and Hepatitis B Immunisation at Birth
Beyond the preview
Go deeper on BCG vaccine + hepatitis B vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCG vaccine + hepatitis B vaccine.